The correlation between image-based HER2 quantification after uptake of 68Ga-NOTA-2Rs15d in local or distant metastases of breast cancer patients and the results obtained by biopsy of the same lesion (NCT03924466) is under investigation in a further phase II clinical trial (VUBAR). The gene discussed is ERBB2; the disease is breast carcinoma.